Michelle Leona Cecil: Microhealth – Digital Health Platform for Bleeding Disorders Community
Michelle Leona Cecil, Community Digital Advocate at MicroHealth, WFH Susan Skinner Memorial Fund Scholarship Advisory and Selection Committee Member, shared a post on LinkedIn:
“Microhealth (digital hematology): a free, safe, and secure digital health platform built specifically for the bleeding disorders community.
For more than 15 years, Microhealth has been helping individuals and families manage their care with confidence. As an independent platform, it has become one of the most widely used digital health tools in the bleeding disorders community.
The only app where you can log treatments in as few as 3 taps.
Simply open the app, select Log Treatment, scan the QR code on your treatment box, add any additional details you wish (including infusion site, notes, and photos), and save.
Track more than treatments.
Microhealth allows users to document bleeds, symptoms, notes, and photos while generating personalized summaries that provide valuable insights into how a bleeding disorder is affecting daily life over time.
Built for individuals and families.
Users can create up to five profiles, supporting a wide range of bleeding disorders and treatment products, making it easier to manage care for multiple family members within a single platform.
Strengthen communication with your care team.
With user consent, Microhealth can connect directly with Hemophilia Treatment Centers (HTCs), allowing individuals to:
- Message their care team
- Share photos and updates
- Ask questions between visits
- Provide clinicians with a comprehensive summary of treatments, bleeds, symptoms, and other key health information
Access your data when and where you need it.
Users can generate comprehensive PDF reports that can be used for:
- Clinical appointments
- Insurance documentation
- Advocacy efforts
- Travel preparation
- Personal health record management
Your data. Your decision.
Microhealth puts users in control of their information.
Whether you choose to contribute anonymized and de-identified data to support research or keep your information completely private, the decision is always yours.
Committed to privacy, security, and quality.
Microhealth is an FDA certified medical device and maintains:
- ISO 13485 Certification — the internationally recognized standard for medical device quality management systems
- SOC 2 Type II Certification — independently validating controls related to security, availability, and confidentiality
- HIPAA-compliant practices and multiple additional safeguards designed to protect user information
A global community.
Today, Microhealth is trusted by individuals and families in more than 140 countries and is available in multiple languages.
Our mission remains simple: empower people with bleeding disorders with tools that make care management easier, strengthen connections with care teams, and give individuals greater control over their health information.
If you haven’t explored Microhealth yet, I encourage you to learn more and see how it can support your bleeding disorders journey.
Find more posts featuring Michelle Leona Cecil on Hemostasis Today.
-
Jun 5, 2026, 16:13Why Do Patients with Similar Conditions Bleed Differently? – EAHAD
-
Jun 5, 2026, 15:59Erica Brock: A Closer Look at Our Care Model for Individuals and Families Affected by Bleeding Disorders
-
Jun 5, 2026, 15:53Andjelka Stones: Key Findings on Hemophilia A Gene Therapy
-
Jun 5, 2026, 15:52Atieh Karimzadeh: Romiplostim Shows High Response and Reduced Bleeding in Pediatric HSCT
-
Jun 5, 2026, 15:50Venugopalan Unni: D-Dimer and Pulmonary Embolism
-
Jun 5, 2026, 15:48Surbhi Singh: Platelet Satellitism – When Platelets Cluster Around Neutrophils and Mimic Thrombocytopenia
-
Jun 5, 2026, 15:39Wolfgang Miesbach: CMA CAR-T Induces Immune Reset and Durable Remission in Refractory ITP – EHA 2026 Late-Breaking Update
-
Jun 5, 2026, 15:34Ney Carter Borges: Low-Dose Rivaroxaban in Advanced Chronic Kidney Disease – Lessons From the TRACK Trial
-
Jun 5, 2026, 15:29Nethuki Kulasinghe: Sequential Anticoagulation in Postpartum Iliocaval Thrombosis With Submassive PE and HIT